139 related articles for article (PubMed ID: 2116232)
21. Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.
Luna T; Santos SB; Nascimento M; Porto MA; Muniz AL; Carvalho EM; Jesus AR
Braz J Med Biol Res; 2011 Nov; 44(11):1134-40. PubMed ID: 22011961
[TBL] [Abstract][Full Text] [Related]
22. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
Novaes R; Freire-de-Lima CG; de Albuquerque RC; Affonso-Mitidieri OR; Espindola O; Lima MA; de Andrada Serpa MJ; Echevarria-Lima J
Immunobiology; 2013 Sep; 218(9):1166-74. PubMed ID: 23669236
[TBL] [Abstract][Full Text] [Related]
23. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
[TBL] [Abstract][Full Text] [Related]
24. In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
Izaki M; Yasunaga JI; Nosaka K; Sugata K; Utsunomiya H; Suehiro Y; Shichijo T; Yamada A; Sugawara Y; Hibi T; Inomata Y; Akari H; Melamed A; Bangham C; Matsuoka M
PLoS Pathog; 2021 Feb; 17(2):e1009271. PubMed ID: 33524072
[TBL] [Abstract][Full Text] [Related]
25. HTLV-1 drives vigorous clonal expansion of infected CD8(+) T cells in natural infection.
Melamed A; Laydon DJ; Al Khatib H; Rowan AG; Taylor GP; Bangham CR
Retrovirology; 2015 Nov; 12():91. PubMed ID: 26552867
[TBL] [Abstract][Full Text] [Related]
26. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.
Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH
J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312
[TBL] [Abstract][Full Text] [Related]
27.
Otaguiri KK; Dos Santos DF; Slavov SN; Depieri LV; Palma PVB; Meirelles FV; Covas DT; da Silveira JC; Kashima S
AIDS Res Hum Retroviruses; 2018 Dec; 34(12):1075-1082. PubMed ID: 30229663
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and functional changes in gamma delta T lymphocytes from HTLV-1 carriers.
Cavalcanti De Albuquerque R; Granato A; Silva Castro I; Carvalho Torres R; Santos Souza F; Lima MA; Celestino Bezerra Leite AC; de Melo Espíndola O; Echevarria-Lima J
J Leukoc Biol; 2019 Sep; 106(3):607-618. PubMed ID: 31287591
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous neutrophil activation in HTLV-1 infected patients.
Guerreiro JB; Porto MA; Santos SB; Lacerda L; Ho JL; Carvalho EM
Braz J Infect Dis; 2005 Dec; 9(6):510-4. PubMed ID: 16410947
[TBL] [Abstract][Full Text] [Related]
30. Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection.
Rahman S; Khan ZK; Wigdahl B; Jennings SR; Tangy F; Jain P
J Immunol; 2011 Jan; 186(1):390-402. PubMed ID: 21115731
[TBL] [Abstract][Full Text] [Related]
31. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
[TBL] [Abstract][Full Text] [Related]
32. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.
Miyazato P; Yasunaga J; Taniguchi Y; Koyanagi Y; Mitsuya H; Matsuoka M
J Virol; 2006 Nov; 80(21):10683-91. PubMed ID: 16943297
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of human immunodeficiency virus type 1 envelope protein gp120 on interferon production by mononuclear cells from adults and neonates.
Nair MP; Chadha KC; Stadler I; Sweet A; Schwartz SA
Clin Diagn Lab Immunol; 1995 Jul; 2(4):434-8. PubMed ID: 7583919
[TBL] [Abstract][Full Text] [Related]
34. Immune responses and serum levels of cytokines in adult T-cell leukemia patients and human T-cell leukemia virus type-I carriers.
Nakasone T; Araki K; Masuda M; Oshiro K; Arakaki H; Shimoji T; Shinzato O; Mimura G
Eur J Haematol; 1992 Feb; 48(2):99-104. PubMed ID: 1547882
[TBL] [Abstract][Full Text] [Related]
35. Antiproliferative activity of cyclopentenone prostaglandins in early HTLV-1 infection is independent of IL-2 and is associated with HSP70 induction.
D'Onofrio C; Franzese O; De Marco A; Bonmassar E; Amici C
Leukemia; 1994 Jun; 8(6):1045-56. PubMed ID: 7516027
[TBL] [Abstract][Full Text] [Related]
36. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.
Santos SB; Porto AF; Muniz AL; de Jesus AR; Magalhães E; Melo A; Dutra WO; Gollob KJ; Carvalho EM
BMC Infect Dis; 2004 Mar; 4():7. PubMed ID: 15070424
[TBL] [Abstract][Full Text] [Related]
37. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
38. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).
Olière S; Hernandez E; Lézin A; Arguello M; Douville R; Nguyen TL; Olindo S; Panelatti G; Kazanji M; Wilkinson P; Sékaly RP; Césaire R; Hiscott J
PLoS Pathog; 2010 Nov; 6(11):e1001177. PubMed ID: 21079688
[TBL] [Abstract][Full Text] [Related]
39. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.
Yssel H; de Waal Malefyt R; Duc Dodon MD; Blanchard D; Gazzolo L; de Vries JE; Spits H
J Immunol; 1989 Apr; 142(7):2279-89. PubMed ID: 2466894
[TBL] [Abstract][Full Text] [Related]
40. In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.
Hilburn S; Rowan A; Demontis MA; MacNamara A; Asquith B; Bangham CR; Taylor GP
J Infect Dis; 2011 Feb; 203(4):529-36. PubMed ID: 21208912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
